||Donald E. Low, M.D., FRCPC
Department of Microbiology,
Mount Sinai Hospital, Room 1485
600 University Ave, Toronto Ontario, M5G 1X5
Phone: (416) 586-4435
Fax: (416) 586-8746
Dr. Low, a fellow of the Royal College of Physicians
and Surgeons of Canada, completed his undergraduate training and
postgraduate training in medicine and infectious diseases at the
University of Manitoba and his training in Medical Microbiology
at the University of Toronto. He is a Fellow of the American Academy
Dr. Low's primary research interests are in the study
of the epidemiology and the mechanisms of antimicrobial resistance
in community and hospital pathogens. Other research interests
include the epidemiology, pathogenesis, and treatment of streptococcal
diseases. His group is recognized internationally for their Canadian
population-based surveillance programs for the study of antimicrobial
resistance and infectious diseases.
A recognized authority in microbiology and infectious
diseases, Dr. Low has published more than 170 papers in peer-reviewed
journals and is a reviewer for several organizations including
the Medical Research Council, Health and Welfare Canada, New England
Journal of Medicine, Journal of American Medical Association,
and the Proceedings of the National Academy of Science. He is
also an Associate Editor of the Canadian Journal of Infectious
Dr. Low is Head of the Department of Microbiology at
the University Health Network and Mount Sinai Hospital, a diagnostic
laboratory serving 10 hospitals in the Greater Toronto Area. He
is a Professor at the University of Toronto in the Department
of Laboratory Medicine and Pathobiology and Department of Medicine.
He is currently Head of the Division of Microbiology in the Department
of Laboratory Medicine and Pathobiology.
For More Articles by Dr. Low Click Here
- Wolter N, Smith AM, Low DE, Klugman KP.
High-level telithromycin resistance in a clinical isolate of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 51(3):1092-5, 3/8/2007.
- Mehta S, McGeer A, Low DE, Hallett D, Bowman DJ, Grossman SL, Stewart TE.
Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU.
Chest 130(6):1679-86., 12/1/2006.
- Hanselman BA, Kruth SA, Rousseau J, Low DE, Willey BM, McGeer A, Weese JS.
Methicillin-resistant Staphylococcus aureus colonization in veterinary personnel.
Emerg Infect Dis. 12(12):1933-8, 12/1/2006.
- Bast DJ, Dresser L, Duncan CL, Walker SE, Mandell LA, Low DE, de Azavedo JC.
Short-course therapy of gemifloxacin effective against pneumococcal pneumonia in mice
J Chemother 18(6):634-40, 12/1/2006.
- Lowe DO, Mamdani MM, Kopp A, Low DE, Juurlink DN.
Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study.
Clin Infect Dis. 43(10):1272-6., 11/15/2006.
- Valiquette L, Low DE, Chow R, McGeer AJ.
A survey of physician's attitudes regarding management of severe group A streptococcal infections.
Scand J Infect Diseases. 38(11-12):977-82., 11/1/2006.
- Roberts A, Bitnun A, McGeer A, Tran D, Yau Y, Simpson K, Green K, Lowe DE, Ford-Jones EL.
Laboratory-confirmed influenza-associated hospitalizations among children in the metropolitan Toronto and Peel region by active surveillance, 2004-2005.
Can Commun Dis Rep. 32(18):203-7., 9/15/2006.
- Daneman N, McGeer A, Green K, Low DE; Toronto Invasive Bacterial Diseases Network. Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Macrolide resistance in bacteremic pneumococcal disease: implications for patient management.
Clin Infect Dis. 43(4):432-8., 8/15/2006.
- De Azavedo JC, Duncan CL, Kilburn L, Downar J, Kong B, Lad S, Low DE, Bast DJ.
Relative potential for selection of quinolone-resistance-determining-region mutations in Streptococcus pneumoniae by gemifloxacin, gatifloxacin and moxifloxacin.
J Chemother 18(4):373-8., 8/1/2006.
- Olsen CW, Karasin AI, Carman S, Li Y, Bastien N, Ojkic D, Alves D, Charbonneau G, Henning BM, Low DE, Burton L, Broukhanski G.
Triple reassortant H3N2 influenza A viruses, Canada, 2005.
Emerg Infect Dis. 12(7):1132-5, 7/1/2006.
Advisory Committee/External Organizations
- Chairman, Microbiology Committee, Quality Management
Program, Laboratory Services, Ontario Medical Association
- Member, National Committee on Clinical Laboratory
Standards Subcommittee on Antimicrobial Susceptibility Testing,
Wayne, PA, USA
- Editorial board, Journal of Antimicrobial Chemotherapy
- Editorial Board, Antimicrobial Agents and Chemotherapy
- 1999. Janssen-Ortho Distinguished Service Award, Canadian
Infectious Disease Society
- 1999. Louis Weinstein Award for the best clinical article
published in Clinical Infectious Diseases between July 1998 and
- 2000. Divisional A. Lecture, Lost opportunities, future
challenges. Surveillance and Its Role in R&D Symposium. 100th
American Society for Microbiology General Meeting, Los Angeles,
- 2001. 2001 BD Award for Research in Clinical Microbiology,
American Academy of Microbiology.
- 2001. Divisional C. Lecture, Examining Resistance in Streptococcus
pneumoniae: Perspectives. 101st American Society for Microbiology
General Meeting, Orlando, Florida, 2001.
This website has been made possible through an unrestricted educational grant from
Pfizer Canada Inc.